Skip to main content
Fig. 7 | BMC Medicine

Fig. 7

From: The expression profiles of signature genes from CD103+LAG3+ tumour-infiltrating lymphocyte subsets predict breast cancer survival

Fig. 7

The ability of the CLTRP score to predict chemotherapeutic benefit. A Pairwise comparison of the CLTRP score in patients before and after chemotherapy. B, C Boxplot exhibiting the distribution of the CLTRP score for breast cancer patients with different chemotherapy responses. Right panel: Bar graph displaying the numbers of clinical responses to chemotherapy in the high and low CLTRP subgroups. D The CLTRP-low subgroup receiving chemotherapy is associated with improved prognosis. E The IC50 values of chemotherapeutic drugs in the high and low CLTRP subgroups. **p < 0.01, ***p < 0.001, ****p < 0.0001, measured by unpaired t test

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us